SARAH OBRADOVICH: Open Payments
NPI 1801236518 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,097 in 89 payments from 20 companies in 2025. Trend: 2023 $1,792 · 2024 $1,879 · 2025 $2,097
Food & beverage: $2,009Education: $88
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 17 | $550 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $281 |
| AstraZeneca Pharmaceuticals LP | 9 | $245 |
| GENZYME CORPORATION | 7 | $183 |
| PFIZER INC. | 12 | $151 |
| ABBVIE INC. | 4 | $92 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| BioCryst US Sales Co., LLC | 3 | $70 |
| Grifols USA, LLC | 3 | $69 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $68 |
Products named: DUPIXENT, FASENRA, TEZSPIRE, TAKHZYRO, HYQVIA, RINVOQ, CUVITRU, ORLADEYO.
Industry payments across FL — which companies pay providers there.
